Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|April 2, 2003
Identification of a novel urokinase receptor splice variant and its prognostic relevance in breast cancerThomas Luther, Matthias Kotzsch, Axel Meye, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2022
Herpes simplex virus alters Alzheimer's disease biomarkers - A hypothesis paperOliver Goldhardt, Robert Freiberger, Tobias Dreyer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2005
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancerMatthias Kotzsch, Juliane Farthmann, Axel Meye, et al.
Breast Cancer Research and Treatment|October 24, 2007
Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factorMatthias Kotzsch, Anieta M Sieuwerts, Marianne Grosser, et al.
BMC Cancer|December 19, 2014
Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasisSusanne Fuessel, Kati Erdmann, Helge Taubert, et al.
Cancers|December 1, 2020
KLK4 Induces Anti-Tumor Effects in Human Xenograft Mouse Models of Orthotopic and Metastatic Prostate CancerBrian W-C Tse, Thomas Kryza, Mei-Chun Yeh, et al.
Neoplasia (New York, N.Y.)|January 25, 2025
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancerStefanie Seitz, Tobias F Dreyer, Christoph Stange, et al.
Biological Chemistry|February 26, 2010
Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancerLina Seiz, Matthias Kotzsch, Nicolai I Grebenchtchikov, et al.
Carcinogenesis|October 6, 2019
miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional studyKonstantina Panoutsopoulou, Margaritis Avgeris, Konstantinos Mavridis, et al.
Biological Chemistry|March 19, 2026
Development of kallikrein-related peptidase 7 (KLK7) inhibitors and use in a species-adapted model for ovarian cancerTorsten Steinmetzer, Laury S Mesa-Rangel, Sadaf Janghorban, et al.
Pageof 13